| MAYNE PHARMA GROUP LTD. |
| Australien |
| Gesundheit |
| AU000000MYX0 / A1C821 |
| HG6 (Frankfurt) |
| FRA:HG6, ETR:HG6, HG6:GR |
| - |
| http://www.maynepharma.co.. |
|
Mayne Pharma Group Ltd. is a specialty pharmaceutical company focused on the development, manufacture, and commercialization of branded and generic pharmaceutical products. Headquartered in Salisbury, Australia, the company operates globally with key..
>Volltext.. |
| 116.13 Mio. EUR |
| 101.75 Mio. EUR |
| 235.33 Mio. EUR |
| 13.43 Mio. EUR |
| -48.11 Mio. EUR |
| -0.59 EUR |
| 24.55 Mio. EUR |
| 38.93 Mio. EUR |
| 13.83 Mio. EUR |
| 0.26 |
| 6.18% |
| 30.54% |
| - |
| - |
| - |
| 18.01.23 - 6.0656006€ 03.03.11 - 1.5764872€ >weitere anzeigen... |
| - |
| MAYNE PHARMA |
| 04.04.26 |
|